J9185 HCPCS code: Injection, fludarabine phosphate, 50 mg
J9185 is the HCPCS Level II code for injection, fludarabine phosphate, 50 mg. In 2024 Medicare paid an average of $144.23 per service for J9185 across 700 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 2 per day on outpatient hospital claims. Medicare volume fell 12% from 2022 to 2024 (795 to 700 services). In 2024, about 141 clinicians billed Medicare for J9185 for 136 beneficiaries; Illinois, Texas, Missouri accounted for 71% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1994-01-01 |
| Last action effective | 2023-01-01 |
Who bills J9185 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 141 |
| Medicare beneficiaries | 136 |
| States with claims | 5 |
| Share of services in top 3 states (Illinois, Texas, Missouri) | 71% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9185, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 795 | 151 | $63.26 | $50.17 |
| 2023 | 837 | 167 | $301.73 | $240.20 |
| 2024 | 700 | 136 | $181.41 | $144.23 |
States with the most J9185 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Illinois | 151 | $147.93 |
| Texas | 136 | $141.00 |
| Missouri | 91 | $141.73 |
| Florida | 85 | $144.97 |
| Virginia | 66 | $158.40 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 2 | Prescribing Information |
| practitioner claims | 2 | Prescribing Information |
What changed for J9185
- 1994-01-01: J9185 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9185?
J9185 is the HCPCS Level II code for injection, fludarabine phosphate, 50 mg. Short descriptor: "Fludarabine phosphate inj".
How much does Medicare pay for J9185?
In 2024, the average Medicare payment was $144.23 per service (average allowed $181.41).
Does Medicare cover J9185?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J9185 can be billed per day?
2 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9185
- Watch J9185 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9185
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.